Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Active-Controlled, Phase 3 Study of Chronocort Compared With Immediate-Release Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Conditions
Interventions
Chronocort
Cortef
+1 more
Locations
21
United States
Diurnal Investigational Site in Los Angeles
Los Angeles, California, United States
Diurnal Investigational Site in Orange
Orange, California, United States
Diurnal Investigational Site in Jacksonville
Jacksonville, Florida, United States
Diurnal Investigational Site in Iowa
Iowa City, Iowa, United States
Diurnal Investigational Site in Maryland
Bethesda, Maryland, United States
Diurnal Investigational Site in Michigan
Ann Arbor, Michigan, United States
Start Date
May 24, 2022
Primary Completion Date
February 2, 2024
Completion Date
February 2, 2024
Last Updated
February 25, 2025
NCT06573723
NCT06712823
NCT03760835
NCT04463316
NCT07536269
NCT05907291
Lead Sponsor
Neurocrine UK Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions